Fate Therapeutics (FATE) Short term Debt (2012 - 2019)
Fate Therapeutics' (FATE) quarterly Short term Debt came in at $13.9 million in Q3 2019, up 326.84% YoY from $3.3 million in Q3 2018, and up 155.77% on a QoQ basis from $5.4 million in Q2 2019.
Fate Therapeutics (FATE) Short term Debt (2012 - 2019) Analysis & Trends
Fate Therapeutics (FATE) has 8 years of Short term Debt data on file, last reported at $13.9 million in Q3 2019.
- Quarterly Short term Debt rose 326.84% year-over-year to $13.9 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $13.9 million (up 326.84% YoY) and the FY2018 annual result came in at $2.4 million, changed N/A from the prior year.
- Short term Debt grew to $13.9 million in Q3 2019, from $5.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $13.9 million in Q3 2019 to a low of $758000.0 in Q1 2018.
- A 5-year average of $5.9 million and a median of $6.0 million in 2015 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2015 — Short term Debt surged 962.85% — and 2018, when it tumbled 90.12%.
- Tracing FATE's Short term Debt over 5 years: stood at $7.7 million in 2015, then climbed by 6.48% to $8.2 million in 2016, then retreated by 6.3% to $7.7 million in 2017, then slumped by 68.22% to $2.4 million in 2018, then jumped by 471.45% to $13.9 million in 2019.
- The last three Short term Debt figures came in at $13.9 million (Q3 2019), $5.4 million (Q2 2019), and $3.9 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 13.93 Mn |
| Jun 30, 2019 | 5.45 Mn |
| Mar 31, 2019 | 3.94 Mn |
| Dec 31, 2018 | 2.44 Mn |
| Sep 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 2.01 Mn |
| Mar 31, 2018 | 758,000.00 |
| Mar 31, 2017 | 7.67 Mn |
| Dec 31, 2016 | 8.19 Mn |
| Sep 30, 2016 | 8.11 Mn |
| Jun 30, 2016 | 7.97 Mn |
| Mar 31, 2016 | 7.71 Mn |
| Dec 31, 2015 | 7.69 Mn |
| Sep 30, 2015 | 6.49 Mn |
| Jun 30, 2015 | 5.16 Mn |
| Mar 31, 2015 | 3.26 Mn |
| Dec 31, 2014 | 1.54 Mn |
| Sep 30, 2014 | 611,000.00 |
| Jun 30, 2014 | 746,000.00 |
| Mar 31, 2014 | 1.24 Mn |